Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-004837
Filing Date
2020-04-09
Accepted
2020-04-09 14:44:11
Documents
1
Period of Report
2020-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158645783421178.html 4  
1 FORM 4 wf-form4_158645783421178.xml 4 3970
  Complete submission text file 0001628280-20-004837.txt   5482
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE 800 HOUSTON TX 77030
Business Address
Foster Aaron E. (Reporting) CIK: 0001767877 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 20784064